Chemists develop Washington Red dye for bio-imaging
Scientists have created an injectable dye that illuminates molecules with near-infrared light...
List view / Grid view
Scientists have created an injectable dye that illuminates molecules with near-infrared light...
A team of scientists in the United States has identified a mechanism that explains the development of hyperaldosteronism. These findings offer a potential path for drug discovery to treat the condition, which often leads to secondary hypertension.
While attempting to position two chips on a microscope, an involuntary exhalation by scientist Greg Madejski caused them to adhere to great effect.
A new probe has the potential to help surgeons visualise primary non-fluorescing, low-grade gliomas during surgery to remove the tumour.
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.1
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and found a compound that stops the disease in its tracks.
Charles River Laboratories International, Inc. announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited.
Scientists have provided a therapeutic approach to slow down the progression of neurodegeneration in Alzheimer's disease...
A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
Reducing a protein found in the mitochondria of cardiac muscle cells initiates cardiac dysfunction and heart failure...
A study has shown that disruption to cell autophagy is involved in the development of pancreatic cancer.
Recent study shows how a microscope using ultraviolet (UV) light to illuminate samples enables pathologists to assess high-resolution images of biopsies and other fresh tissue samples for disease, quickly and effectively.
A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer's disease by stopping toxic ion flow in the brain...
Researchers have found that amyloid-? facilitates the interaction between the plaques and abnormal tau.
Results from a new study suggest that DNA sequencing could soon become part of the routine diagnostic examination for patients with chronic kidney disease.